Q3 2024 Earnings Call Transcript November 5, 2024 Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.8. Operator: Good day, and thank you for ...

Third Quarter 2024 Results Key Financial Results Revenue: US$33.3m (up 48% ...

Even though Agios Pharmaceuticals, Inc. ( NASDAQ:AGIO ) posted strong earnings recently, the stock hasn't reacted in ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

Merko Ehitus Eesti, part of the Merko Ehitus group, has entered into a design-and-build construction contract with the Estonian Centre for Defence Investment for the construction of a National Defence ...

Detailed price information for Exxon Mobil Corp (XOM-N) from The Globe and Mail including charting and trades.

Multiconsult, a Norwegian company in engineering, architecture, and design consulting, has reported earnings before interest, ...

The global electrical insulation materials market is experiencing a strong growth trajectory, projected to expand from USD 11 ...

The 34-year-old Vanderpump Rules star's episode on the 35-year-old Kansas City Chiefs tight end's game show Are You Smarter ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

英为财情Investing.com - Supernus Pharmaceuticals (NASDAQ: SUPN)星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.69，总营收为$175.69M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$157.3M，每股收益为 ...